• SENSEX 77,235.46
    -492.70 (--0.63%)
  • BANKNIFTY 57,497.80
    6.70 (+0.01%)
  • Billionbrains
    190.70 112.02(%)
  • Lenskart Solut.
    638.00 627.35(%)
  • Cupid
    285.50 298.95(%)
  • Embassy Off.REIT
    438.80 375.00(%)
  • ICICI Pru Life
    500.60 459.60(%)
  • Dhoot Transmission
    1,306.25 1,212.70(%)
  • Netweb Technol.
    5,398.00 5,272.55(%)
  • ICICI Lombard
    1,615.00 1,544.40(%)
  • Molbio Diagnosti
    1,175.00 1,064.85(%)
  • Max Healthcare
    1,016.50 1,258.95(%)
  • Cyient
    850.00 751.00(%)
  • Multi Comm. Exc.
    3,057.10 3,479.80(%)
  • P I Industries
    2,542.40 3,916.00(%)
  • Jindal Steel
    1,101.90 943.50(%)
  • Baazar Style
    403.65 426.85(%)
  • Sun Pharma.Inds.
    1,868.50 1,547.25(%)
  • Schaeffler India
    4,099.00 4,465.00(%)
  • Reliance Industries
    1,328.00 1,611.20(%)
  • Dixon Technolog.
    14,420.80 18,471.50(%)
  • Paras Defence
    1,527.65 1,444.95(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Novartis India Ltd Pharmaceuticals - Multinational

  • MNC Associate
  • BSE Code : 243.0
  • ISIN : INE234A01025
1,589.10 7 (0.42%)
  • As on 18 Aug 2026 (EOD)

  • Today’s Low

    1,576.00

  • Today’s High

    1,627.70

  • Open

    1,590.40

  • Perv Close

    1,582.50

  • 52W Low

    950.00

  • 52W High

    1,780.00

Key Indicators

  • P/E(TTM)

    40.13

  • Mar.Cap (₹Cr.)

    3,923.61

  • Div & Yield %

    0.00

  • Book Value(₹)

    331.23

  • Debt-Equity Ratio

    0.42

  • AGM Date

    17-Aug-2026

  • EPS

    39.60

  • P/E Ratio

    40.13

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    3,923.61

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    12.35

  • BV (₹)

    331.20

  • Sales( ₹ in Cr.)

    354.33

  • NP (in Cr.)

    93.18

  • NP Var(%)

    -8.0

  • Div%

    0.0

  • CPS (₹)

    38.50

  • EPS (₹)

    37.70

  • Traded Value (₹ in Lakhs)

    3,923.86

  • 52 Week High

    1,780.00

  • 52 Week Low

    950.00

  • Price BSE

    1589.0

  • Price NSE

    1,589.00

  • Market Capital( in Cr.)

    3,923.86

  • P/C Ratio

    41.20

  • P/E Ratio

    42.10

  • Price Vs.BV

    37.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 390.09 366.84 413.52 486.66 453.73 532.69
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 390.09 366.84 413.52 486.66 453.73 532.69
Other Income 41.96 61.68 58.11 33.19 33.09 36.14
Stock Adjustments -3.75 -9.86 -2.35 9.12 -10.74 -1.83
Total Income 428.30 418.66 469.28 528.97 476.08 567.00
EXPENDITURE :            
Raw Materials 199.07 189.98 199.34 187.26 135.88 180.49
Power and Fuel Cost 0.14 0.18 0.35 0.53 0.53 1.27
Employee Cost 18.72 22.96 35.64 101.89 108.51 113.87
Other Manufacturing Expenses 8.18 5.00 12.58 31.15 33.51 36.19
Selling and Administration Expenses 59.74 65.55 82.78 144.40 128.11 174.87
Miscellaneous Expenses 9.07 8.05 15.40 53.08 9.66 12.14
Employee Benefit Expenses 18.72 22.96 35.64 101.89 108.51 113.87
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 294.92 291.72 346.09 518.31 416.20 518.83
Operating Profit 133.38 126.94 123.19 10.66 59.88 48.17
Interest 0.77 1.49 1.75 4.83 7.68 6.39
Gross Profit 132.61 125.45 121.44 5.83 52.20 41.78
Depreciation 2.19 2.61 6.06 9.65 12.16 13.14
Profit Before Tax 130.42 122.84 115.38 -3.82 40.04 28.64
Current Tax 29.96 37.63 1.68 -0.44 22.62 15.22
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.44 0.02 10.34 0.34 -3.48 3.34
Reported Net Profit 100.90 85.19 103.36 -3.72 20.90 10.08
Extraordinary Items 0.08 1.99 0.17 -44.68 0.03 -0.01
Adjusted Net Profit 100.82 83.20 103.19 40.96 20.87 10.09
Adjustment below Net Profit 0.97 1.21 3.11 8.19 -6.09 -24.81
P & L Balance brought forward 728.84 759.72 677.94 698.16 708.04 747.46
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 61.73 117.28 24.69 24.69 24.69 24.69
P & L Balance carried down 768.98 728.84 759.72 677.94 698.16 708.04
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 500.00 500.00 950.00 200.00 200.00 200.00
Dividend Per Share(Rs) 25.00 25.00 47.50 10.00 10.00 10.00
Earnings Per Share-Unit Curr 40.88 34.52 41.88 -1.51 8.47 4.08
Earnings Per Share(Adj)-Unit Curr 40.88 34.52 41.88 -1.51 8.47 4.08
Book Value 318.06 301.79 314.29 280.27 288.16 292.03
Book Value(Adj)-Unit Curr 318.06 301.79 314.29 280.27 288.16 292.03

Shareholding Pattern

  • Promoter Group

    70.68%

  • Public Share Holding

    29.32%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 13,938,382 56.45 13,938,382 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 13,938,382 56.45 13,938,382 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,512,298 14.23 3,512,298 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,512,298 14.23 3,512,298 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 2,604 0.01 1,907 12
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 38,234 0.15 38,234 4
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 80,441 0.33 80,441 1
Mutual Funds / UTI 178,865 0.72 178,405 7
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 80,794 0.33 80,794 5
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 380,938 1.54 379,781 29
2] Non Institution
Bodies Corporate 571,934 2.32 571,894 215
Clearing Members 17,085 0.07 17,085 25
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 264,801 1.07 262,859 888
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 280,235 1.14 280,225 890
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 782,199 3.17 782,199 7
Individuals holding nominal share capital up to Rs. 1 lakh 4,755,001 19.26 4,559,394 34,631
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,036 0.00 1,036 3
Others 174,759 0.71 174,759 1
Sub Total 6,859,179 27.78 6,661,455 36,674
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 24,690,797 100.00 24,491,916 36,706

Company Background

Novartis India LtdPharmaceuticals - Multinational

  • Novartis India Ltd
  • BSE Code : 243.0
  • ISIN : INE234A01025

  • Incorporation Year

    1947

  • Registered Office

    The Inspire BKC Part 601 & 701
    Bandra Kurla Complex Bandra(E), Mumbai,
    Maharashtra-400051

  • Telephone

    91-022-50243000

  • FAX

    91-022-50243010

  • Chairman

    C Snook

  • Managing Director

  • Company Secretary

    Chandni Maru

  • Auditor

    B S R & Co LLP

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Novartis India Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Novartis India 1,589.20 398.23 356.27 40.13 16.64
Abbott India 26,933.65 7,217.19 6,929.05 35.45 43.78
Astrazeneca Phar 7,628.85 2,304.07 2,275.58 112.44 27.86
Sanofi India 3,198.00 1,857.10 1,837.40 22.75 54.17
Glaxosmi. Pharma 2,699.80 3,932.76 3,790.20 43.13 58.17
Cipla 1,430.00 20,102.60 18,979.95 37.58 13.88
Bliss GVS Pharma 519.50 773.53 729.81 48.24 12.51
Amrutanjan Healt 492.55 469.50 451.82 26.38 21.89
Fermenta Biotec. 458.25 474.15 450.25 21.39 18.77
Guj. Themis Bio. 352.80 152.47 150.80 78.93 27.21
Ambalal Sarabhai 45.69 19.52 3.94 84.61 6.77